Home » Market News » DirectorsTalk Highlights » Dr Cath O’Neill Recognised as One of the Top 50 Female Leaders in UK Healthcare
SkinBiotherapeutics Plc

Dr Cath O’Neill Recognised as One of the Top 50 Female Leaders in UK Healthcare

Dr Cath O’Neill, Chief Executive Officer of SkinBiotherapetics PLC (LON:SBTX) caught up with Proactive Investors after being named one of healthcare’s top movers and shakers as part of BioBusiness’ 2017 50 Movers and Shakers report.

Video source: Proactive Investors

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.